Abstract
IntroductionPregnancies in patients with systemic lupus erythematosus (SLE) are associated with an increased risk of adverse maternal (including flares) and fetal outcomes. Hydroxychloroquine (HCQ) decreases disease activity and the occurrence...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
